Effects of dynorphin A (1-13) on carbon monoxide-induced delayed amnesia in mice

Pharmacology Biochemistry and Behavior

Volumn 56, Issue 1, 1996, Pages 73-79

  Hiramatsu, M ^a   Sasaki, M ^a   Nabeshima, T ^b   Kameyama, T ^a  

^a MEIJO UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

carbon monoxide; cholinergic neuronal system; delayed amnesia; dynorphin A (1 13); kappa opioid receptor; learning; nor binaltorphimine; spontaneous alternation performance

Indexed keywords

CARBON MONOXIDE; DIZOCILPINE; DYNORPHIN[1-13]; KAPPA OPIATE RECEPTOR; MECAMYLAMINE; NORBINALTORPHIMINE;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLINERGIC SYSTEM; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LEARNING; MALE; MAZE TEST; MEMORY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMNESIA; ANIMALS; CARBON MONOXIDE POISONING; DIZOCILPINE MALEATE; DYNORPHINS; EXCITATORY AMINO ACID ANTAGONISTS; INJECTIONS, INTRAVENTRICULAR; MALE; MAZE LEARNING; MECAMYLAMINE; MICE; MICE, INBRED STRAINS; NALTREXONE; NARCOTIC ANTAGONISTS; NARCOTICS; NICOTINIC ANTAGONISTS; PEPTIDE FRAGMENTS; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, OPIOID, KAPPA;

EID: 0031033195     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00159-1     Document Type: Article

References (49)

1. + or glutamic acid from rat neostriatal slices. Brain Res. 523:1990;51-56.
2. Bartus R. T., Dean R. L., Beer B., Lippa A. S. The cholinergic hypothesis of geriatric memory dysfunction. Science. 217:1982;408-417.
3. Beninger R. J., Wirsching B. A., Jhamandas K., Boegman R. J. Animal studies of brain acetylcholine and memory. Arch. Gerontol. Geriatr. Suppl. 1:1989;71-78.
4. Bunnell D. E., Horvath S. M. Interactive effects of physical work and carbon monoxide on cognitive task performance. Aviat. Space Environ. Med. 59:1988;1133-1138.
5. Buresova O., Bolhuis J. J., Bures J. Differential effects of cholinergic blockade on performance of rats in the water tank navigation task and in a radial water maze. Behav. Neurosci. 100:1986;476-482.
6. Coyle J. T., Price D. L., Delong M. R. Alzheimer's disease. a disorder of cortical cholinergic innervation Science. 219:1983;1184-1190.
7. Danysz W., Wroblewski J. T. Amnesic properties of glutamate receptor antagonists. Neurosci. Res. Commun. 5:1989;9-18.
8. Dunnett S. B., Whishaw I. Q., Jones G. H., Bunch S. T. Behavioral, biochemical and histochemical effects of different neurotoxic amino acids injected into nucleus basalis magnocellularis of rats. Neuroscience. 20:1987;653-669.
9. Ginsberg M. D. Delayed neurological deterioration following hypoxia. Adv. Neurol. 26:1979;21-44.
10. Haley T. J., McCormick W. G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br. J. Pharmacol. 12:1957;12-15.
11. Heinrichs R. W. Relationship between neuropsychological data and response to behavioral treatment in a case of carbon monoxide toxicity and dementia. Brain Cognition. 14:1990;213-219.
12. Hiller J. M., Itzhak Y., Simon E. J. Selective changes in mu, delta and kappa opioid receptor binding in certain limbic regions of the brain in Alzheimer's disease patients. Brain Res. 406:1987;17-23.
13. Hiramatsu M., Kameyama T., Nabeshima T. Carbon monoxide-induced impairment of learning, memory and neuronal dysfunction. Penny D. G. Carbon monoxide. An old foe reviseted:1996;187-210 CRC Press, New York.
14. Hiramatsu M., Koide T., Ishihara S., Shiotani T., Kameyama T., Nabeshima T. Involvement of the cholinergic system in the effects of nefiracetam (DM-9384) on carbon monoxide (CO)-induced acute and delayed amnesia. Eur. J. Pharmacol. 216:1992;279-285.
15. Hiramatsu M., Mori H., Murasawa H., Kameyama T. Improvement by dynorphin A (1-13) galanin-induced impairment of memory accompanied by blockade of reductions in acetylcholine release in rats. Br. J. Pharmacol. 118:1996;255-260.
16. Hiramatsu M., Sasaki M., Kameyama T. Effects of dynorphin A-(1-13) on carbon monoxide-induced delayed amnesia in mice studied in a step-down type passive avoidance task. Eur. J. Pharmacol. 282:1995;185-191.
17. Hiramatsu M., Satoh H., Kameyama T., Nabeshima T. Nootropic effect of nicotine on carbon monoxide (CO)-induced delayed amnesia in mice. Psychopharmacology. 116:1994;33-39.
18. Ichihara K., Nabeshima T., Kameyama T. Differential effects of pimozide and SCH 23390 on acquisition of learning in mice. Eur. J. Pharmacol. 164:1989;189-195.
19. Introini-Collison I. B., Cahill L., Baratti C. M., McGaugh J. L. Dynorphin induces task-specific impairment of memory. Psychobiology. 15:1987;171-176.
20. Ishimaru H., Nabeshima T., Katoh A., Suzuki H., Fukuta T., Kameyama T. Effects of successive carbon monoxide exposures on delayed neuronal death in mice under the maintenance of normal body temperature. Biochem. Biophys. Res. Commun. 179:1991;836-840.
21. Ishimaru H., Katoh A., Suzuki H., Fukuta T., Kameyama T., Nabeshima T. Effects of N-methyl-D-aspartate receptor antagonists on carbon monoxide-induced brain damage in mice. J. Pharmacol. Exp. Ther. 261:1992;349-352.
22. Itoh J., Ukai M., Kameyama T. Dynorphin A-(1-13) markedly improves scopolamine-induced impairment of spontaneous alternation performance in mice. Eur. J. Pharmacol. 236:1993;341-345.
23. Itoh J., Ukai M., Kameyama T. Dopaminergic involvement in the improving effects of dynorphin A-(1-13) on scopolamine- induced impairment of alternation performance. Eur. J. Pharmacol. 241:1993;99-104.
24. Izquierdo I., De Almeida M. A. M. R., Emiliano V. R. Unlike β-endorphin, dynorphin 1-13 does not cause retrograde amnesia for shuttle avoidance or inhibitory avoidance learning in rats. Psychopharmacology. 87:1985;216-218.
25. Jiang H. -K., Owyang V., Hong J. -S., Gallagher M. Elevated dynorphin in the hippocampal formation of aged rats. Relation to cognitive impairment on a spatial learning task Proc. Natl. Acad. Sci. USA. 86:1989;2948-2951.
26. Kameyama T., Nabeshima T., Noda Y. Cholinergic modulation of memory for step-down type passive avoidance task in mice. Res. Commun. Psychol. Psychiat. Behav. 11:1986;193-205.
27. Levin E. D. Nicotinic systems and cognitive function. Psychopharmacology. 108:1992;417-431.
28. Maurice T., Hiramatsu M., Itoh J., Kameyama T., Hasegawa T., Nabeshima T. Behavioral evidence for a modulating role of σ ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia Brain Res. 647:1994;44-56.
29. Maurice T., Hiramatsu M., Kameyama T., Hasegawa T., Nabeshima T. Behavioral evidence for a modulating role of σ ligands in memory processes. II. Reversion of carbon monoxide (CO)-induced amnesia Brain Res. 647:1994;57-64.
30. Maurice T., Hiramatsu M., Kameyama T., Hasegawa T., Nabeshima T. Cholecystokinin-related peptides, after systemic or central administration, prevent carbon monoxide-induced amnesia in mice. J. Pharmacol. Exp. Ther. 269:1994;665-673.
31. Min S. K. A brain syndrome associated with delayed neuropsychiatric sequelae following acute carbon monoxide intoxication. Acta Psychiatr. Scand. 73:1986;80-86.
32. Mori H., Hiramatsu M., Suzuki H., Kameyama T. Changes in monoamine concentraions in brain induced by dynorphin A (1-13) using in vivo microdialysis. Folia Pharmacol. Jpn. 102:1993;88P.
33. Morris R. G. M., Anderson E., Lynch G. M., Baudry M. Selective impairment of learning and blockade of long-term potentiation by a N-methyl-D-aspartate receptor antagonists, AP5. Nature. 319:1986;774-776.
34. Mulder A. H., Wardeh G., Hogenboom F., Frankhuyzen A. L. κ- and δ-Opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release. Nature. 308:1984;278-281.
35. Nabeshima T., Katoh A., Ishimaru H., Yoneda Y., Ogita K., Murase K., Ohtsuka H., Inari K., Fukuta T., Kameyama T. Carbon monoxide-induced delayed amnesia, delayed neuronal death and change in acetylcholine concentration in mice. J. Pharmacol. Exp. Ther. 256:1991;378-384.
36. Nabeshima T., Yoshida S., Morinaka H., Kameyama T., Thurkauf A., Rice K. C., Jacobson A. E., Monn J. A., Cho A. K. MK-801 ameliorates delayed amnesia, but potentiates acute amnesia induced by CO. Neurosci. Lett. 108:1990;321-327.
37. Newhouse A. Cholinergic drug studies in dementia and depression. Adv. Exp. Med. Biol. 282:1990;65-76.
38. O'Dell T. J., Christensen B. N. Mecamylamine is a selective noncompetitive antagonist of NMDA and ASP-induced currents in horizontal cells dissociated from the catfish retina. Neurosci. Lett. 94:1988;93-98.
39. Oei T. P. S., King M. G. Catecholamines and aversive learning. A review Neurosci. Biobehav. Rev. 4:1980;161-173.
40. Parada-Turska J., Turski W. A. Excitatory amino acids antagonists and memory. Effect of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks Neuropharmacology. 29:1990;1111-1116.
41. Ronken E., Van Muiswinkel F. L., Mulder A. H., Schoffelmeer N. M. Opioid receptor-mediated inhibition of evoked catecholamine release from cultured neurons of rat ventral mesencephalon and locus coeruleus. Eur. J. Pharmacol. 230:1993;349-355.
42. Sarter M. Taking stock of cognition enhancers. Trends Pharmacol. Sci. 12:1991;456-461.
43. Sarter M., Bodewitz G., Stephens D. N. Attenuation of scopolamine-induced impairment of spontaneous alternation behavior by antagonist but not inverse agonist and agonist β-carbolines. Psychopharmacology. 94:1988;491-495.
44. Scarpace P. J., Abrass I. B. Alpha- and beta-adrenergic receptor function in the brain during senescence. Neurobiol. Aging. 9:1988;53-58.
45. Ukai M., Kobayashi T., Kameyama T. Dynorphin A-(1-13) attenuates basal forebrain-lesion-induced amnesia in rats. Brain Res. 625:1993;355-356.
46. Venable N., Kelly P. H. Effects of NMDA receptor antagonists on passive avoidance learning and retrieval in rats and mice. Psychopharmacology. 100:1990;215-221.
47. Whitehouse P. J., Martino A. M., Antuono P. G., Lowenstein P. R., Coyle J. T., Price D. L., Kellar K. J. Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Res. 371:1986;146-151.
48. Wirsching B. A., Beninger R. J., Jhamandas K., Boegman R. J., El-Defrawy S. R. Differential effects of scopolamine on working and reference memory of rats in the radial maze. Pharmacol. Biochem. Behav.; 20:1984;659-662.
49. Yoshida S., Nabeshima T., Kinbara K., Kameyama T. Effects of NIK-247 on CO-induced impairment of passive avoidance in mice. Eur. J. Pharmacol. 214:1992;247-252.